Flot.bio on Youtube Flot.bio on Spotify Flot.bio on Apple Podcasts
background-splash

Tag: Immatics

Immatics specializes in T-cell receptors (TCRs) and has made significant strides in immunotherapy. With bispecific antibodies in phase three and promising TCR therapies, the company is positioning itself as a leader in the immuno-oncology space. The founder, Harpreet Singh, was on the show recently for episode 20, so please feel free to check it out.

Never miss a new episode 💌

Trusted by 350+ professionals from top companies like Argenx, BioNTech, or Genmab. No spam, no noise.

Watch & Subscribe

Flot.bio on Youtube Flot.bio on Spotify Flot.bio on Apple Podcasts